Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.34 |
| ▸ | SLC2A3 | P11169 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CCNE1 | P24864 | 11/20 | 0.34 |
| ▸ | CDK2 | P24941 | 11/20 | 0.34 |
| ▸ | CCND1 | P24385 | 7/20 | 0.34 |
| ▸ | CDK6 | Q00534 | 7/20 | 0.34 |
| ▸ | TTK | P33981 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CCNT1 | O60563 | 3/20 | 0.33 |
| ▸ | CDK4 | P11802 | 3/20 | 0.33 |
| ▸ | CDK9 | P50750 | 3/20 | 0.33 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11944278 | 0.91 | CCND1 (0.33) | ALDH1A1DCTPP1SLC2A1SLC2A2SLC2A3 | |
| SCHEMBL11944164 | 0.89 | KDM4E (0.39) | ALDH1A1CNR2 | |
| SCHEMBL11944212 | 0.88 | ALDH1A1 (0.43) | ALDH1A1DCTPP1SLC2A1SLC2A2SLC2A3 | |
| SCHEMBL11944165 | 0.86 | POLB (0.42) | ALDH1A1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL11944264 | 0.86 | ALDH1A1 (0.43) | ALDH1A1DCTPP1SLC2A1SLC2A2SLC2A3 | |
| SCHEMBL11944199 | 0.85 | ALDH1A1 (0.44) | ALDH1A1DCTPP1SLC2A1SLC2A2SLC2A3 | |
| SCHEMBL11944222 | 0.82 | ALDH1A1 (0.40) | ALDH1A1DCTPP1SLC2A1SLC2A2SLC2A3 | |
| SCHEMBL11944193 | 0.79 | ALDH1A1 (0.45) | ALDH1A1DCTPP1SLC2A1SLC2A2SLC2A3 | |
| SCHEMBL11944279 | 0.79 | ALDH1A1 (0.48) | ALDH1A1DCTPP1SLC2A1SLC2A3SMN1; SMN2 | |
| SCHEMBL11944340 | 0.78 | HRH3 (0.35) | ALDH1A1DCTPP1SLC2A1SLC2A2SLC2A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8232274-B2 | Pyridazinone derivatives useful as glucan synthase inhibitors | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-8232274-B2 | Pyridazinone derivatives useful as glucan synthase inhibitors | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. | 2009-07-02 | — | — | US | disclosed |
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170861-A1 | Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors | MAN2A1, GYS2, MANBA | ALDH1A1 2437/4885DCTPP1 625/4885SLC2A1 1099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.